Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

594 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Immunological evaluation of peptide vaccination for patients with gastric cancer based on pre-existing cellular response to peptide.
Sato Y, Shomura H, Maeda Y, Mine T, Une Y, Akasaka Y, Kondo M, Takahashi S, Shinohara T, Katagiri K, Sato M, Okada S, Matsui K, Yamada A, Yamana H, Itoh K, Todo S. Sato Y, et al. Among authors: mine t. Cancer Sci. 2003 Sep;94(9):802-8. doi: 10.1111/j.1349-7006.2003.tb01522.x. Cancer Sci. 2003. PMID: 12967479 Free article. Clinical Trial.
Peptide vaccination for patients with melanoma and other types of cancer based on pre-existing peptide-specific ctotoxic T-lymphocyte precursors in the periphery.
Tanaka S, Harada M, Mine T, Noguchi M, Gohara R, Azuma K, Tamura M, Yamada A, Morinaga A, Nishikori M, Katagiri K, Itoh K, Yamana H, Hashimoto T. Tanaka S, et al. Among authors: mine t. J Immunother. 2003 Jul-Aug;26(4):357-66. doi: 10.1097/00002371-200307000-00008. J Immunother. 2003. PMID: 12843798 Clinical Trial.
Immunological evaluation of personalized peptide vaccination with gemcitabine for pancreatic cancer.
Yanagimoto H, Mine T, Yamamoto K, Satoi S, Terakawa N, Takahashi K, Nakahara K, Honma S, Tanaka M, Mizoguchi J, Yamada A, Oka M, Kamiyama Y, Itoh K, Takai S. Yanagimoto H, et al. Among authors: mine t. Cancer Sci. 2007 Apr;98(4):605-11. doi: 10.1111/j.1349-7006.2007.00429.x. Epub 2007 Feb 19. Cancer Sci. 2007. PMID: 17309598 Free article. Clinical Trial.
Immunological evaluation of personalized peptide vaccination in combination with a 5-fluorouracil derivative (TS-1) for advanced gastric or colorectal carcinoma patients.
Sato Y, Fujiwara T, Mine T, Shomura H, Homma S, Maeda Y, Tokunaga N, Ikeda Y, Ishihara Y, Yamada A, Tanaka N, Itoh K, Harada M, Todo S. Sato Y, et al. Among authors: mine t. Cancer Sci. 2007 Jul;98(7):1113-9. doi: 10.1111/j.1349-7006.2007.00498.x. Epub 2007 Apr 23. Cancer Sci. 2007. PMID: 17459063 Free article. Clinical Trial.
Immunological evaluation of personalized peptide vaccination in refractory small cell lung cancer.
Terazaki Y, Yoshiyama K, Matsueda S, Watanabe N, Kawahara A, Naito Y, Suekane S, Komatsu N, Ioji T, Yamada A, Mine T, Terasaki M, Itoh K, Takamori S, Sasada T. Terazaki Y, et al. Among authors: mine t. Cancer Sci. 2012 Apr;103(4):638-44. doi: 10.1111/j.1349-7006.2012.02202.x. Epub 2012 Feb 13. Cancer Sci. 2012. PMID: 22321067 Free PMC article. Clinical Trial.
594 results